Cure8

Why This Matters

If confirmed, molecular or microbial markers found at surgery could help identify Crohn’s patients at higher risk of postoperative endoscopic recurrence and inform closer monitoring or preventative strategies after resection.

Who Should Pay Attention

Researchers studying IBD biomarkers and microbiome, clinicians who manage postoperative Crohn’s patients, and patients who have had or will undergo ileal resection.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This preprint reports a small study that looked for molecular and microbial signals in ileal tissue taken at the time of bowel resection that were linked with endoscopic recurrence six months later.

Researchers performed RNA sequencing and 16S bacterial profiling on the same FFPE ileal sections from 24 Crohn’s patients and compared those who later had endoscopic recurrence to those who did not.

Tissue that later recurred already showed higher expression of inflammatory and immune pathways (interferon, TNF/NF-κB, IL-6, complement) even though the proximal ileal margin appeared macroscopically normal.

The mucosal microbiome composition also differed; several genera such as Acinetobacter, Christensenellaceae_R-7_group, and Desulfovibrio had nominal differences in relative abundance. The authors performed exploratory correlations between bacterial genera and host gene modules to suggest linked host–microbe changes.

Because the study is small (n=24) and reported as hypothesis-generating, these findings are preliminary. They suggest that molecular and microbial features in resection-margin tissue might help predict postoperative endoscopic recurrence, but they are not ready for clinical use and need validation in larger cohorts.

Keep In Mind

Structured-content depth: abstract from a posted preprint on ResearchSquare. The sample size is small (24 patients) and analyses are exploratory; results are hypothesis-generating and require independent validation. No clinical recommendations or validated predictive tests are reported.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationSpringer Science and Business Media LLC
AuthorsMoting Liu, Dianne Jansen, Tjasso Blokzijl +8 more
Study typePosted Content
Indexed viaCrossref
Source typeResearch paper
PublishedSep 4, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →